Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Isenberg

Showing results (251-260 of 519) with videos related to

Pageof 52
Sort By:
Thrombosis Research|November 15, 1993
Immunoelectrophoresis and ELISA techniques for assay of plasma beta 2 glycoprotein-1 and the influence of plasma lipidsT McNally, I J Mackie, D A Isenberg, et al.
Clinical and Experimental Immunology|August 1, 1993
Elevation of heat shock protein synthesis and hsp gene transcription during monocyte to macrophage differentiation of U937 cellsB M Twomey, S McCallum, D A Isenberg, et al.
British Journal of Rheumatology|June 10, 1998
Erosive arthritis in systemic lupus erythematosus: analysis of a distinct clinical and serological subsetM Richter Cohen, G Steiner, J S Smolen, et al.
Rheumatology (Oxford, England)|June 18, 2003
Definition and treatment of lupus flares measured by the BILAG indexC Gordon, N Sutcliffe, J Skan, et al.
Rheumatology International|January 1, 1991
Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agendaM H Liang, P R Fortin, D A Isenberg, et al.
Arthritis and Rheumatism|December 2, 2006
Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosusK P Ng, J J Manson, A Rahman, et al.
Clinical Rheumatology|April 24, 2009
Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-upK P Ng, F Ramos, S M Sultan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Elevated levels of beta 2 glycoprotein-I (beta 2 GPI) in antiphospholipid antibody syndrome are due to increased amounts of beta 2 GPI in association with other plasma constituentsT McNally, I J Mackie, S J Machin, et al.
Thrombosis and Haemostasis|August 1, 1996
beta 2 glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: the effect of antibodies from plasma of patients with antiphospholipid syndromeT McNally, I J Mackie, D A Isenberg, et al.
Annals of the Rheumatic Diseases|October 1, 1996
Further validation of the BILAG disease activity index in patients with systemic lupus erythematosusT Stoll, G Stucki, J Malik, et al.
Pageof 52

Showing results (251-260 of 519) with videos related to

Sort By:
Pageof 52
Thrombosis Research|November 15, 1993
Immunoelectrophoresis and ELISA techniques for assay of plasma beta 2 glycoprotein-1 and the influence of plasma lipidsT McNally, I J Mackie, D A Isenberg, et al.
Clinical and Experimental Immunology|August 1, 1993
Elevation of heat shock protein synthesis and hsp gene transcription during monocyte to macrophage differentiation of U937 cellsB M Twomey, S McCallum, D A Isenberg, et al.
British Journal of Rheumatology|June 10, 1998
Erosive arthritis in systemic lupus erythematosus: analysis of a distinct clinical and serological subsetM Richter Cohen, G Steiner, J S Smolen, et al.
Rheumatology (Oxford, England)|June 18, 2003
Definition and treatment of lupus flares measured by the BILAG indexC Gordon, N Sutcliffe, J Skan, et al.
Rheumatology International|January 1, 1991
Quantitative clinical assessment of disease activity in systemic lupus erythematosus: progress report and research agendaM H Liang, P R Fortin, D A Isenberg, et al.
Arthritis and Rheumatism|December 2, 2006
Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosusK P Ng, J J Manson, A Rahman, et al.
Clinical Rheumatology|April 24, 2009
Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-upK P Ng, F Ramos, S M Sultan, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 1, 1995
Elevated levels of beta 2 glycoprotein-I (beta 2 GPI) in antiphospholipid antibody syndrome are due to increased amounts of beta 2 GPI in association with other plasma constituentsT McNally, I J Mackie, S J Machin, et al.
Thrombosis and Haemostasis|August 1, 1996
beta 2 glycoprotein-I inhibits factor XII activation on triglyceride rich lipoproteins: the effect of antibodies from plasma of patients with antiphospholipid syndromeT McNally, I J Mackie, D A Isenberg, et al.
Annals of the Rheumatic Diseases|October 1, 1996
Further validation of the BILAG disease activity index in patients with systemic lupus erythematosusT Stoll, G Stucki, J Malik, et al.
Pageof 52